CHELSEY ASLETT: Open Payments
NPI 1124851357 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 32 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $370 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $146 |
| ABBVIE INC. | 4 | $105 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| Geron Corporation | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Janssen Biotech, Inc. | 2 | $38 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $34 |
| PFIZER INC. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
Products named: IMFINZI, LIBTAYO, ELAHERE, RYTELO, LYNPARZA, ERLEADA, NERLYNX, XTANDI.
Industry payments across ID — which companies pay providers there.
